Marie‐Elisabeth Toubert

Author

Also Known As

C. Dejax, M E Toubert, M-E Toubert, M. E. Toubert, M.-E. Toubert, M.E Toubert, M.E. Toubert, M.‐E. Toubert, MARIE-ELISABETH TOUBERT, Marie-Elisabeth Toubert

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Hôpital Saint-Louis Université Paris Cité Sorbonne Université Assistance Publique – Hôpitaux de Paris Institut Gustave Roussy

About

Marie‐Elisabeth Toubert is an author at Hôpital Saint-Louis specializing in medicine, health sciences, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	543
2	Health Sciences	10	10	513
3	Engineering	3	3	184
4	Cell Biology	1	1	11
5	Hepatology	1	1	58

Marie‐Elisabeth Toubert

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer Martin Schlumberger, Bogdan Catargi, Isabelle Borget, New England Journal of Medicine	2012	681
Management of Graves’ Disease during Pregnancy: The Key Role of Fetal Thyroid Gland Monitoring Dominique Luton, Isabelle Le Gac, Edith Vuillard, The Journal of Clinical Endocrinology & Metabolism	2005	295
Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients Maryse Brassard, Isabelle Borget, Agathe Edet‐Sanson, The Journal of Clinical Endocrinology & Metabolism	2011	231
Comparison of Seven Serum Thyroglobulin Assays in the Follow-Up of Papillary and Follicular Thyroid Cancer Patients Martin Schlumberger, Anne Hitzel, Marie‐Elisabeth Toubert, The Journal of Clinical Endocrinology & Metabolism	2007	207
Localization of a Susceptibility Gene for Familial Nonmedullary Thyroid Carcinoma to Chromosome 2q21 James D. McKay, Fabienne Lesueur, Laurence Jonard, The American Journal of Human Genetics ChromatinGenetic DisorderGeneticsThyroid DiseasePathology	2001	189
Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer David Groheux, Elif Hindié, Marc Delord, JNCI Journal of the National Cancer Institute	2012	158
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial Martin Schlumberger, Sophie Leboulleux, Bogdan Catargi, The Lancet Diabetes & Endocrinology Cancer ManagementThyroid DiseaseLow-risk Thyroid CancerEquivalence TrialOncology	2018	158
Relationship between Immunological Structure and Biochemical Properties of Human Thyroid Peroxidase Jean Ruf, Marie‐Elisabeth Toubert, Barbara Czarnocka, Endocrinology	1989	145
<sup>18</sup>F-FDG PET/CT in Staging Patients with Locally Advanced or Inflammatory Breast Cancer: Comparison to Conventional Staging David Groheux, Sylvie Giacchetti, Marc Delord, Journal of Nuclear Medicine	2012	137
Effect of 18F-FDG PET/CT Imaging in Patients With Clinical Stage II and III Breast Cancer David Groheux, Jean‐Luc Moretti, Georges Baillet, International Journal of Radiation OncologyBiologyPhysics Positron Emission Tomography18F-fdg Pet/ct ImagingEngineeringMedical ImagingOncologic Imaging	2008	118

Page 1